Background: The immunologic response to stress is regulated by the cytokines. Anti-Tumor Necrosis Factor-α agents are antibodies directed against a key cytokine in the process angiogenesis and collagen synthesis. It is not known whether they intervene with surgical stress response increasing the rate of postoperative complications. Method: Un-blinded prospective, non-interventional cohort single centre study including all the patients with Crohn's disease and Ulcerative Colitis undergoing abdominal surgery. Immunological and endocrinological parameters will measured in blood samples taken from these patients before and after surgery. Power calculations showed that 17 patients in each arm are needed.
The baseline patient characteristics will be evaluated based on pilot tested data extraction sheets. The assessment will include demographics, clinical data as well as laboratory work up. The Charlson morbidity index, will be used to assess co-morbidity, the Nutritional risk score (NRS) to assess nutrition status and the Harvey-Bradshaw index (HBI) to evaluate the activity of Crohn's disease. The duration of surgical procedure, along with the amount of blood transfused, will be recorded in all patients. Laboratory variables The following variables will be assessed based on previous evidence about their role in surgical stress response: 1. Immunological parameters: Tumor necrosis factor-alpha, interleukin-1, interleukin-6, interleukin-10, C reactive protein, and white blood cell counts. 2. Endocrinological parameters: plasma cortisol, growth hormone , adrenocorticotropic hormone, epinephrin and norepinephrine
Study Type
OBSERVATIONAL
Enrollment
47
Treatment with biologics
Århus University Hospital
Aarhus, Denmark
Slagelse Hospitals
Copenhagen, Denmark
Køge Hospital
Køge, Denmark
OUH
Odense, Denmark
changes in inflammatory cytokines
Primary outcome measure is the change in inflammatory cytokines Tumor Necrosis Factor-alpha, interleukin -1, interleukin -6, interleukin -10
Time frame: pre-operative, at time of induction of anaethesia, 6,24 and 48 hours after the operation
30 postoperative day complications.
Secondary outcome measure is 30 postoperative day complications.
Time frame: 30 days after operation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.